DIGENE | LABS

Home

theHPVtest.com

Newsroom

Sitemap

Digene in the Lab

A leader in molecular diagnostics, Digene develops, manufactures and markets integrated technology solutions to help laboratories screen, monitor and diagnose women's infectious diseases and cancer. Our proprietary Hybrid Capture^® 2 (hc2) technology serves as the platform that provides laboratories with molecular diagnostics products and testing instruments systems designed for clinical accuracy and laboratory efficiency.

Digene's laboratory molecular diagnostics products include:

The Digene HPV Test*, our flagship product,
Chlamydia (CT) and Gonorrhea (GC) tests, and
Tests for blood viruses

In combination, Digene offers proprietary modular instrument systems designed to provide laboratories with the automation they need to achieve maximum efficiency while meeting optimal performance and sensitivity. Accurate, cost-effective, and user-friendly, you can meet your laboratory's throughput with ease. Be able to use a comprehensive risk-screening approach based on one patient visit / specimen by testing multiple nucleic acid targets (HPV, CT and GC) using one platform. The instrument systems include

The Hybrid Capture^® System for low throughput laboratories
The Rapid Capture^TM System for high throughput laboratories

With Digene's best in class molecular diagnostics products and instrument systems, you'll stay ahead of the game while meeting industry demands.

Digene technology offers laboratories the following:

Signal–amplification nucleic acid testing with immunoassay simplicity
Both large– and small–batch processing to meet laboratories' changing test needs
Excellent high and low volume testing options
Clinically proven results – clear, objective, reproducible, and accurate
No false positives caused by cross–over contamination – amplifies signal, not target
Simplified procedure which minimizes hands–on time
No enzymatic inhibition that may cause false negatives
96–well format which reduces pipetting steps

Digene products are available worldwide through our network of sales specialists and distributors. Digene is committed to providing laboratories with innovative, cost–effective and time–saving molecular diagnostic technologies, while supporting its customers with comprehensive and knowledgeable customer service.

* "The Digene HPV^® Test" was approved by the US FDA and is also known to laboratories and physicians as the "hc2 High–Risk HPV DNA Test^®" and "DNAwithPap^® Test." This does not refer to the Digene product that tests for several types of the virus commonly referred to as "low–risk HPV," which are not associated with cervical cancer.